Due to the lack of complete vaccination anywhere in the world, the virus can mutate again and create new strains. Immunizations are aimed at blocking the spike protein of the virus. But if vaccines are not taken, the Kovid virus can infect human cells and make thousands of copies. When new copies are created in this way, something goes wrong and a mutation occurs. It causes new variants to emerge. For example, experts believe that the latest variant, Omicron, was created by mutating the Kovid virus into an AIDS patient’s body.
In such a situation, it is important to vaccinate those most at risk of contracting the virus, which has spread around the world, first, and then to vaccinate the rest of the population. Or, as it happens, mutations that cause mutations may become more powerful and reach the body of those who have been vaccinated, from where mutations may occur to create more dangerous variants and cause the extinction of the human race itself.
A new reality has now emerged that rich and more developed countries are hoarding vaccines and preventing the equitable sharing of crucial information about the epidemic for commercial gain. Poor countries are being hit harder and harder.
What is the nationality of the vaccine?
Vaccine nationalization occurs when governments enter into agreements with pharmaceutical manufacturers to distribute the vaccine to their own people before the vaccine becomes available in other countries.
According to a report in the Harvard Political Review, the company had paid $ 1.2 billion to AstraZeneca by May 2020 to accelerate vaccine research. The US agreement was to replace Astrazeneca’s 300 million vaccine doses. The UK had made a similar deal. Later, rich countries such as Japan and Canada signed similar agreements worth billions of dollars. Even before the epidemic reached its peak, countries with 16% of the world’s population monopolized more than half of the available vaccine doses. As of January this year, those countries had reportedly purchased 96% of the Pfizer / Bioentech vaccines and 100% of the modona doses scheduled for production by the end of the year.
According to the World Bank in August this year, four billion doses of the vaccine were given worldwide. At this stage, 27.6% of the world’s population has received at least one vaccine. But when the data is listed by country income, only 1.1% of people living in low-income countries receive even a single dose of the vaccine.
” These figures are based on the percentage of the population. But when it comes to the percentage of doses up to July 28, 84% of all doses given so far went to people in high- and middle-income countries. This is a shocking figure compared to the percentage of doses given in low-income countries. Only 0.3% of doses are given in low-income countries, ”explains the World Bank’s Development Podcast.
At a recent UN convention, Namibian President Hugo Jingbo said, “The situation is so serious that the vaccine is racist and many developing countries are not included as equals.” In some countries, citizens are in the process of receiving booster shots. Many in other countries are still waiting to receive their first doses. It is unfortunate that such a situation exists. “
However, hoarding of the vaccine will not help the developed world. If developed countries are vaccinated against inequality and the developing world lags behind, new mutations will eventually become a threat to the world. A live example of this is the Delta variant, which has the potential to expand at a higher rate. Many developed countries have already vaccinated large sections of their population. There are only a small number of people left who are reluctant to get vaccinated due to various social and political factors.
The only way to defeat the epidemic
Even the World Health Organization’s COVAX initiative to help developing countries is underfunded. It is reported that more than 20% of the developing world’s population will not be able to be vaccinated unless funds are provided promptly and vaccine orders are placed.
Unilateralism is not good for the world. Global crises such as epidemics and climate change are leading to a multifaceted approach globally. “The world must fully and unequivocally embrace pluralism, international cooperation and solidarity as the only way to defeat the epidemic,” said Livingstone Seveniana, of the UN Independent Expert of International Order.
As the epidemic and its devastating consequences continue to wreak havoc on the world, Livingston Seveniana emphasizes the importance of adopting ‘renewed versatility’. ‘In addition to achieving a democratic and just international order, this epidemic is giving the world the opportunity to rebuild and rehabilitate better next time. This must be taken seriously. “
South Africa and India have previously called on the World Trade Organization (WTO) to suspend ‘intellectual property’ laws related to Kovid-19 to ensure that not only rich countries have access to vaccines, drugs and other new technologies needed to control the epidemic. But the pharmaceutical industry and many high-income countries are strongly opposed to the move. They argue that it will hinder innovation when it is most needed. According to the report, India will lead next week’s WTO meeting on intellectual property rights exemptions for the distribution and distribution of Kovid-19 vaccines.
In a post-colonial world, political and social experts argue that the intellectual property legal system should be guided by the principles of equality, justice and welfare rather than colonial hegemony. Researcher Michael Byronhawk says change is essential in a more dangerous world.
“Third world countries can be given priority on the global intellectual property agenda as part of an alternative shift. The solution is to eliminate colonialism, regional integration and global justice, “said Michael Byrne Hawk.
India’s position
When the vaccine nationalities of the EU countries revealed their duplicity, India carefully backed away from this move. As the ORF report argues, India’s expertise in the pharmaceutical industry has laid the foundation for our vaccine diplomacy. India has delivered vaccines and related items to countries in Asia, Africa and Latin America as part of Operation Vaccine Alliance.
According to exclusive data received by CNN-News 18 this morning, Bharat Biotech has also received approval from the Center to export 108 lakh doses of covaccine commercially due to adequate stock of vaccine in the states.
India exports the vaccine to eight countries, including Paraguay, Botswana, Vietnam, Myanmar, the Philippines, Singapore, Cameroon and the UAE. In the current context, India is making a timely move.
.
